1.Alleles for Associated with Fy(a), Fy(b), Fy(x) and Fy Antigens in a Korean Population.
Kyoung Un PARK ; Ae Ran JEON ; Se Ran HEO ; Junghan SONG ; Kyou Sup HAN
Korean Journal of Blood Transfusion 2005;16(2):209-217
BACKGROUND: In the Duffy blood group system (Fy(a), Fy(b), Fy(x), and Fy antigens), Fy(x) antigen is associated with weak Fy(b) while Fy antigen means the null phenotype Fy (a-b-). Fyx antigen and Fy antigen result from the polymorphisms of Fy125 allele. This report assessed the allele frequency and genotype frequency of Fy(a), Fy(b), Fy(x), and Fy antigens in Koreans. METHODS: We performed a study of the followings on 253 visitors to the health promotion center of Seoul National University Bundang Hospital: PCR-RFLP and PCR-SSP for the detection of Duffy 125G > A and -33T > C; PCR-SSP for the detection of Duffy 265C > T and 298G > A. RESULTS: The results of PCR-RFLP and PCR-SSP were consistent with each other in a total of 253 subjects. Allele frequency was as follows: Fy 92.3%, Fy(125) 6.1%, and fy(125/265) 1.6%. The fy(125/265) allele was newly observed. Fy(125/298), fy(125/265/298), and fy(-33/125) alleles were not detected in Koreans. The distribution of Duffy phenotypes in Koreans was as follows: Fy (a+b-) 88.1%, Fy (a-b+) 0.4%, Fy (a+b+) 11.5%, and Fy (a-b-) 0.0%. Fy (a+) was 99.6% and Fy (b+) was 11.9%. CONCLUSION: In our study for Duffy polymorphisms, the frequency of Fy allele was very high. The frequency was similar to those of other Asian populations, but different from those of Caucasians. The fy(125/265) allele, which was associated with Fy(x) antigen, was newly detected in Koreans.
Alleles*
;
Asian Continental Ancestry Group
;
Duffy Blood-Group System
;
Gene Frequency
;
Genotype
;
Health Promotion
;
Humans
;
Phenotype
;
Polymerase Chain Reaction
;
Seoul
2.Genotype and allele frequencies of the platelet glycoprotein genes associated with arterial thrombosis in Korean population.
Hyung Doo PARK ; Ae Ran JEON ; Sun Kyung JIN ; Kyoung Un PARK ; Junghan SONG ; Kyou Sup HAN ; Jin Q KIM
Korean Journal of Blood Transfusion 2005;16(1):1-13
BACKGROUND: Ischemic heart disease and cerebrovascular disease are the main causes of death and platelets are responsible for the formation of arterial thrombi. Platelet membrane glycoproteins (GP) associated with coagulation pathway are GPIb/V/IX, GPIa/IIa, and GPIIb/IIIa. We evaluated genotype and allele frequencies of seven platelet glycoprotein genes associated with arterial thrombosis. METHODS: Genomic DNA was isolated from peripheral blood of 300 unrelated Korean and single nucleotide polymorphism of platelet glycoproteins was analyzed. PCR with sequence specific primers was used to investigate GPIa C807T and GPIbalpha VNTR polymorphism. PCR-RFLP (restriction fragment length polymorphism) was used to investigate GPIa G1648A and C2531T, GPIbalpha C524T and T-5C, and GPIIIa T1565C polymorphism. RESULTS: The allele frequencies of GPIa C807T were 807C 0.733, 807T 0.267; GPIa 1648G 0.975, 1648A 0.025; GPIa C2531T, 2531C 1.000, 2531T 0.000; GPIbalpha C524T, 524C 0.927, 524T 0.073; GPIbalpha VNTR, A 0.017, B 0.015, C 0.558, D 0.410; GPIbalpha T-5C, -5T 0.726, -5C 0.274; GPIIIa T1565C, 1565T 0.995, 1565C 0.005. CONCLUSION: The genotype and allele frequencies of GPIa G1648A, GPIbalpha C524T, and GPIIIa T1565C were similar to established data. GPIa 807T and -5T allele of Kozak polymorphism showed low frequency compared with other ethnic group. Allele frequencies of GPIbalpha VNTR A and B alleles were very alike (0.017 vs 0.015). In this study, we firstly evaluated the genotype and allele frequencies of GPIa C2531T and GPIbalpha VNTR, T-5C polymorphisms in Korean population. This study will serve as a basic data for the study of platelet glycoproteins associated with arterial thrombosis in Korean.
Alleles*
;
Blood Platelets*
;
Cause of Death
;
DNA
;
Ethnic Groups
;
Gene Frequency*
;
Genotype*
;
Glycoproteins*
;
Humans
;
Integrin alpha2
;
Integrin beta3
;
Myocardial Ischemia
;
Platelet Membrane Glycoproteins
;
Polymerase Chain Reaction
;
Polymorphism, Single Nucleotide
;
Thrombosis*
3.Hard and soft tissue profile changes following anterior subapical osteotomy in bimaxillary dentoalveolar protrusion patients.
Un Ae HAN ; Jeong Hwan KIM ; Tae Ho YOON ; Je Uk PARK ; Yoon Ah KOOK
Korean Journal of Orthodontics 2003;33(6):475-483
The purpose of this study is to evaluate hard and soft tissue changes following the first four premolar extractions and anterior subapical osteotomy in bimaxillary dentoalveolar protrusion patients requiring maximal retraction of anterior segments. A sample of 20 adult female patients was selected. Surgical procedures were performed by the same surgeon, and modified segmental osteotomy and anterior subapical osteotomy techniques were employed on the maxilla and mandible respectively. Presurgical and post-surgical lateral cephalometric radiograms were traced and superimposed using the best-fit method and two reference planes. The results were as follows 1. The bodily movement of the maxillary anterior segment was achieved in a posterior direction. The mandibular anterior segment was moved posteriorly with a slight correction of the lower incisors. 2. The horizontal soft tissue measurements changed significantly after treatment, but Nt and Sn landmarks remained unchanged. The vertical soft tissue measurements indicated that Ls moved inferiorly and Li superiorly. 3. The correlation between hard and soft tissue changes indicated that deltaHId/deltaHLi, deltaHId/deltaLL-Eline, deltaHPt.B/deltaHILS, and deltaUI-FH/deltaNL were significant. 4. More lower lip relative to upper lip retraction was demonstrated in relation to Rickett's E-line. The ratio between upper incisor and upper lip displacement was 50%, and between the lower incisor and lower lip displacement was 60%. We conclude from the results that the anterior subapical osteotomy is an efficient treatment option for adult patients who have severe dentoalveolar protrusion and desire rapid results.
Adult
;
Bicuspid
;
Female
;
Humans
;
Incisor
;
Lip
;
Mandible
;
Maxilla
;
Osteotomy*
4.Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients
Yaewon YANG ; Ahrum MIN ; Kyung-Hun LEE ; Han Suk RYU ; Tae-Yong KIM ; Go-un WOO ; Koung Jin SUH ; Dae-Won LEE ; Han-Byoel LEE ; Hyeong-Gon MOON ; Wonshik HAN ; In Ae PARK ; Dong-Young NOH ; Seock-Ah IM
Journal of Breast Cancer 2020;23(2):182-193
Purpose:
Endocrine therapy is a standard treatment for hormone receptor-positive breast cancer, which accounts for 60%–75% of all breast cancer. Hormone receptor positivity is a prognostic and predictive biomarker in breast cancer. Approximately 50%–80% of breast cancer is also positive for androgen receptor (AR), but the prognostic and predictive value of AR expression in breast cancer is controversial. Here, we investigated AR expression and its prognostic value in patients with surgically resected breast cancer in Korea.
Methods:
We retrospectively reviewed the medical records of patients who had surgically resected breast cancer to collect AR expression data and other clinicopathological data. The optimal cut-off for AR positivity was determined using a receiver operating characteristic curve analysis.
Results:
We reviewed 957 patients with surgically resected breast cancer from June 2012 to April 2013. The median follow-up was 62 months, and relapse events occurred in 101 (10.6%) patients. Unlike the cut-off value of 1% or 10% in previous reports, 35% was determined to be best for predicting relapse-free survival (RFS) in this study. At the cut-off value of 35%, 654 (68.4%) patients were AR-positive. AR expression was more prevalent in luminal A (87.6%) and luminal B (73.1%) types than in human epidermal growth factor receptor 2-positive (56.2%) or triple-negative (20.6%) types. AR expression of ≥ 35% was significantly related to longer RFS in a multivariate analysis (hazard ratio, 0.430; 95% confidence interval, 0.260–0.709; p = 0.001).
Conclusion
We propose a cut-off value of 35% to best predict RFS in patients with surgically resected breast cancer. AR expression was positive in 68.4% of patients, and AR positivity was found to be an independent prognostic factor for longer RFS.
5.A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer
Jung Sun KIM ; Koung Jin SUH ; Dae-Won LEE ; Go-un WOO ; Miso KIM ; Se Hyun KIM ; Han Suk RYU ; Kyung-Hun LEE ; Tae-Yong KIM ; Sae-Won HAN ; So Yeon PARK ; In Ae PARK ; Jee Hyun KIM ; Seock-Ah IM
Cancer Research and Treatment 2022;54(2):488-496
Purpose:
We aimed to assess the real-world efficacy of nab-paclitaxel in metastatic breast cancer patients.
Materials and Methods:
This is a retrospective study performed in two tertiary referral hospitals in Korea. Patients with metastatic breast cancer treated with nab-paclitaxel (Abraxane®) between March 2016 and March 2020 were enrolled.
Results:
A total of 102 patients with metastatic breast cancer were included. Patients were heavily pre-treated with a median of four prior lines of chemotherapy (5 lines when including endocrine therapy in hormone-receptor-positive patients), and 66 patients (64.7%) were exposed to taxanes in the metastatic setting. According to St. Gallen molecular subtypes, 36 patients (35.3%) were luminal A, 28 (27.5%) were luminal B, 18 (17.7%) were human epidermal growth factor receptor 2–positive and 20 (19.6%) had triple-negative disease. Fifty patients (49.0%) were treated with a 3-weekly regimen (260 mg/m2 on day 1 every 3 weeks), and 52 (51.0%) were treated with a weekly regimen (100 mg/m2 every week). Objective response rate was 22.9%. After a median follow-up of 22.0 months, median progression-free survival (PFS) was 4.0 months (95% confidence interval [CI], 2.6 to 4.8) and median overall survival was 8.7 months (95% CI, 7.5 to 11.2). Patients treated with weekly regimen had longer PFS compared to 3-weekly regimen (5.5 vs. 2.3 months, p < 0.001). Multivariate analysis revealed the treatment regimen as an independent prognostic factor for PFS. There was no grade 3 or 4 hypersensitivity reaction.
Conclusion
This real-world data shows that nab-paclitaxel is a reasonable treatment option in heavily pre-treated and/or taxane-exposed metastatic breast cancer patients.
6.Risk Factors For Subtypes of Cerebrovascular Disease in Korea.
Hak Choong LEE ; Bong Ae WEE ; Ock Kyu PARK ; Jung Chae KANG ; Young Ki SHIN ; Shi Rae LEE ; Yo Han PARK ; Wee Hyun PARK ; Young Choon PARK ; Young LEE ; Won Sang YOO ; Un Ho RYOO ; Jeong Euy PARK ; In Suk YANG ; Joon Wook KIM ; Moon Sung CHUNG ; Young Koo CHEE ; Won PARK ; Hong Soon LEE
Korean Circulation Journal 1991;21(6):1081-1095
With a purpose to difine risk factors of respective subtypes of cerebrovascular disease, a case-control study was performed in 1,251 cases with cerebrovascular disease who were admitted to twelve large institutions over the country during the year of 1988. All cases were subtype-proven by computerized tomography. Three hundred and eighty three patients were selected as control among the patients who were admitted to the same hospitals during the same period. The variables were collected prospectively and the data were processed by univariate and multiple logistic regression analyses and the significance was tested by chi-square methods. In the univariate analysis, female sex, being a physical worker, history of hypertension either treated or not and previous stroke history were significantly related with cerebral hemorrhage. Male sex, being aged 60 or more, living in city area, being a mental worker, history of hypertension either treated or not, history of stroke, being a diabetic and positive family history of stroke were significantly related with cerebral infarction. In multiple logistic regression analysis hypertension and alcohol drinking were strong independent risk factors for cerebral hemorrhage. Hypertension, being aged 60 or more, and living in urban area were also independent risk facrots for cerbral infarction. Of the other variables analyzed, socioeconomic class, smoking history or body mass index did not constitute significnat risks for either cerebral hemorrhage or cerebral infarction.
Alcohol Drinking
;
Body Mass Index
;
Case-Control Studies
;
Cerebral Hemorrhage
;
Cerebral Infarction
;
Female
;
Humans
;
Hypertension
;
Infarction
;
Korea*
;
Logistic Models
;
Male
;
Prospective Studies
;
Risk Factors*
;
Smoke
;
Smoking
;
Stroke
7.Annual Report on the External Quality Assessment Scheme for Blood Bank Tests in Korea (2015).
Young Ae LIM ; Hyun Soo CHO ; Seog Woon KWON ; Kye Chul KWON ; Shin Young KIM ; Kyung Un PARK ; Hyun Jun PARK ; Woon Heung SONG ; Duck CHO ; Tae Hyoun UM ; Mee Kyung LEE ; Sang Moo HAN
Journal of Laboratory Medicine and Quality Assurance 2016;38(2):59-67
We report here the results of the external quality assessment scheme (EQA) of blood bank tests in Korea carried out in 2015. The proficiency testing specimens used in the survey were prepared at Ajou University Hospital. The response rates from participating laboratories for the first and second trials were 98.7% (542/549) and 98.2% (544/554), respectively. No answers to tests were considered incorrect, and the average accuracy rates for six different test items on the standard survey were as follows: ABO grouping, 99.4% to 100.0%; RhD typing, 99.4% to 100.0%; crossmatching, 93.6% to 99.0%; direct antiglobulin test (DAT) using a polyspecific reagent, 92.9% to 98.3%; DAT using an IgG monospecific reagent, 94.6% to 100.0%; DAT using a C3d monospecific reagent, 84.2% to 98.6%; unexpected antibody screening test, 94.5% to 100.0%; and antibody identification test, 93.8% to 100.0%. We performed a pilot survey on reactivities to A1 (54 responses) and H (50 responses); Rh C, c, E, and e antigen testing (47 responses); and ABO antibody titration (10-34 responses). We obtained excellent results for this EQA, and these results will be helpful for improving or maintaining the quality of the participating laboratories.
Blood Banks*
;
Coombs Test
;
Immunoglobulin G
;
Korea*
;
Laboratory Proficiency Testing
;
Mass Screening
8.Annual Report on External Quality Assessment of Blood Bank Tests in Korea (2013).
Young Ae LIM ; Jin Sook OH ; Seog Woon KWON ; Kye Chul KWON ; Shin Young KIM ; Kyung Un PARK ; Hyun Jun PARK ; Woon Heung SONG ; Duck CHO ; Tae Hyoun UM ; Kwang HUR ; Sang Moo HAN
Journal of Laboratory Medicine and Quality Assurance 2014;36(2):55-63
We report here the results of surveys for External Quality Assessment (EQA) of blood bank tests carried out in 2013. The proficiency testing specimens were prepared at Ajou University Hospital and sent to 548 and 545 institutes participating in the 1st and 2nd trial, respectively. Test items for the surveys were ABO grouping, RhD typing, crossmatching, direct antiglobulin test (DAT), antibody screening test, and antibody identification test. The response rates for the 1st and 2nd trials were 94.3% and 96.0%, respectively. No answers were considered incorrect answers, and the average accuracy rates of different test items of the survey were as follows: ABO grouping, 98.9% to 100%; RhD typing, 98.4% to 99.2%; crossmatching, 94.4% to 100.0%; DAT using polyspecific reagent, 94.5% to 99.7%; DAT using IgG monospecific reagent, 94.7% to 98.8%; DAT using C3d monospecific reagent, 91.3% to 98.6%; unexpected antibody screening test, 90.9% to 100%; and antibody identification test, 87.3% to 100.0%. Overall, we obtained excellent survey results for the EQA of blood bank tests carried out in 2013, and the number of participating institutes was higher in 2013 than in 2012.
Academies and Institutes
;
Blood Banks*
;
Coombs Test
;
Immunoglobulin G
;
Korea
;
Laboratory Proficiency Testing
;
Mass Screening
9.Annual Report on the External Quality Assessment Scheme for Blood Blank Tests in Korea (2014).
Young Ae LIM ; Jin Sook OH ; Seog Woon KWON ; Kye Chul KWON ; Shin Young KIM ; Kyung Un PARK ; Hyun Jun PARK ; Woon Heung SONG ; Duck CHO ; Tae Hyoun UM ; Mi Kyoung LEE ; Sang Moo HAN
Journal of Laboratory Medicine and Quality Assurance 2015;37(2):47-55
We report here the results of surveys on external quality assessment (EQA) of blood bank tests in Korea carried out in 2014. The proficiency testing specimens were prepared at Ajou University Hospital and the response rates for the 1st and 2nd trials were 94.3% (537/549) and 96.0% (545/554), respectively. No answers were considered incorrect, and the average accuracy rates of six different test items on the regular survey were as follows: ABO grouping, 98.5% to 100.0%; RhD typing, 98.1% to 99.4%; crossmatching, 91.2% to 99.6%; direct antiglobulin test (DAT) using a polyspecific reagent, 96.7% to 98.4%; DAT using an immunoglobulin-G monospecific reagent, 93.8% to 98.7%; DAT using a C3d monospecific reagent, 89.5% to 98.7%; unexpected antibody screening test, 96.2% to 100.0%; and antibody identification test, 69.8% to 100.0%. Test items for the pilot survey were reactivities to anti-A1 and anti-H, Rh subgrouping, and ABO antibody titration. Except for the result of the antibody identification test for specimens with multiple antibodies, we obtained excellent survey results for the EQA of blood bank tests carried out in 2014. In addition, the number of participating institutes was higher in 2014 than in 2013. The EQA of blood bank tests in 2014 should be helpful for improving the quality of the participating laboratories.
Academies and Institutes
;
Antibodies
;
Blood Banks
;
Coombs Test
;
Korea
;
Laboratory Proficiency Testing
;
Mass Screening